SICKLE CELL ANEMIA TESTING AND SCREENING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Regional Analysis

To learn more about this report, Request sample copy

Dominating Region: North America

North America dominates the sickle cell anemia testing and screening market with a share of 39.2% in 2024. This can be attributed to the strong presence of leading diagnostic companies and advanced healthcare infrastructure. Government initiatives to spread awareness about sickle cell disease and promote early detection have boosted the market growth.

Fastest-Growing Region: Asia Pacific

The Asia Pacific region exhibits the fastest growth due to large patient population and rising healthcare expenditure. Developing economies are increasingly investing in healthcare facilities and empowering local diagnostic startups through collaborations and funding.

Sickle Cell Anemia Testing And Screening Market Outlook for Key Regions

Pioneering Sickle Cell Screening Initiatives in the U.S.

The U.S. leads in sickle cell anemia testing due to robust healthcare infrastructure and mandatory newborn screening programs. For instance, in March 2024, the Centers for Disease Control and Prevention (CDC) reported that over 90% of newborns are screened for sickle cell disease, significantly improving early diagnosis and management.

Expanding Access to Testing in Canada

Canada sickle cell testing market is growing, driven by increased awareness and government support for screening programs. In 2020, the Canadian Hematology Society noted a rise in sickle cell disease awareness campaigns, enhancing access to diagnostic services. For instance, in September 2023, approximately 1 in 2,500 to 1 in 5,000 individuals in Canada are affected by sickle cell disease, with a higher prevalence among individuals of African, the Caribbean, and Middle Eastern descent.

Rising Prevalence of Sickle Cell Disease in Japan Amid Globalization

Globalization and increased migration have introduced greater genetic diversity, leading to a rise in sickle cell anemia cases. According to the National Institutes of Health Report, as of May 2024, the prevalence of sickle cell disease in Japan remains relatively low compared to other countries but is increasing due to these factors. This report suggests that approximately 1,000 individuals are living with sickle cell disease in Japan.

Rapid Growth in Screening Programs in China

China's expanding healthcare infrastructure supports the growth of the sickle cell anemia testing and screening market, with increased government funding for genetic research noted in recent years. The prevalence of sickle cell disease is rising, necessitating improved screening methods.

Targeting High-Prevalence Areas in India

India's sickle cell anemia testing and screening market growth is driven by government initiatives targeting sickle cell disease in tribal populations. For instance, according to Press Information Bureau, the Government of India's National Sickle Cell Anaemia Elimination Mission, launched in July 2023, aims to eradicate sickle cell disease (SCD) as a public health issue by 2047. The initiative focuses on screening approximately 70 million individuals aged 0 to 40 years across 278 districts in 17 states, including Maharashtra, over three years.